Coya Therapeutics, Inc. financial data

Symbol
COYA on Nasdaq
Industry
Pharmaceutical Preparations
Location
12645 Memorial Dr., Suite F1 #305, Houston, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 992 % +58.8%
Debt-to-equity 13.9 % -79.5%
Return On Equity -31.6 % +80.1%
Return On Assets -27.8 % +70.7%
Operating Margin -119 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.7M shares +66.6%
Common Stock, Shares, Outstanding 15.2M shares +53%
Entity Public Float 36.4M USD
Common Stock, Value, Issued 1.52K USD +52.9%
Weighted Average Number of Shares Outstanding, Basic 15.2M shares +53%
Weighted Average Number of Shares Outstanding, Diluted 15.2M shares +53%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.55M USD
General and Administrative Expense 9.13M USD +43.6%
Operating Income (Loss) -11.4M USD +3.14%
Net Income (Loss) Attributable to Parent -10.7M USD +13.4%
Earnings Per Share, Basic -0.66 USD/shares +69%
Earnings Per Share, Diluted -0.66 USD/shares +69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31.1M USD +185%
Assets, Current 35.5M USD +200%
Property, Plant and Equipment, Net 45.4K USD -37.6%
Assets 35.6M USD +199%
Accounts Payable, Current 337K USD -46.9%
Accrued Liabilities, Current 1.41M USD +20.2%
Liabilities, Current 2.32M USD +28.4%
Liabilities 3.54M USD +96%
Retained Earnings (Accumulated Deficit) -37.8M USD -39.4%
Stockholders' Equity Attributable to Parent 32M USD +217%
Liabilities and Equity 35.6M USD +199%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.15M USD
Net Cash Provided by (Used in) Financing Activities 1.24M USD -91.3%
Net Cash Provided by (Used in) Investing Activities -25K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 15.2M shares +53%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 5.63M USD +78.9%
Depreciation 27.4K USD 0%
Property, Plant and Equipment, Gross 137K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 439K USD -27.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 69.8M USD +87.7%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.11M USD +199%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%